Literature DB >> 17328986

Endotoxemia contributes to the immune paralysis in patients with cirrhosis.

Chun-Yen Lin1, I-Fan Tsai, Yu-Pin Ho, Ching-Tai Huang, Yung-Chang Lin, Chun-Jung Lin, Shu-Chin Tseng, Wei-Pin Lin, Wei-Ting Chen, I-Shyan Sheen.   

Abstract

BACKGROUND/AIMS: Immune paralysis, defined as decreased HLA-DR expression on monocytes and indicated immune dysfunctions, was found in sepsis, severe acute pancreatitis and acute liver failure. However, the relationship between HLA-DR expression and cirrhosis is unclear.
METHODS: We enrolled 64 patients with liver cirrhosis and 23 healthy volunteers. HLA-DR expressions, functions of monocyte, serum cytokines and endotoxin levels were measured.
RESULTS: Compared to healthy volunteers, HLA-DR expressions were significantly lower in Child-Pugh class C cirrhotic patients (89.28% vs 69.29%, p<0.001). These low-HLA-DR-expressed monocytes were with decreased ability of tumor necrosis factor (TNF)-alpha secretion, decreased expression of inducible nitric oxide synthetase (iNOS) and decreased allo-stimulatory ability but normal phagocytosis ability. The co-stimulatory molecules like CD40 and CD86 were down-regulated as well but not CD80. Furthermore, HLA-DR expression was linearly correlated with the presence of hepatic encephalopathy (r(2)=0.2642; p=0.008) and serum interleukin-10 (IL-10) (r(2)=0.2167; p=0.019) in patients with Child-Pugh class C. Serum endotoxin level was in linear relationship to serum IL-10 level (r(2)=0.1868; p=0.002) and HLA-DR expression (r(2)=0.0924; p=0.036). In addition, endotoxin, mediated by IL-10, could down-regulate the HLA-DR expression.
CONCLUSIONS: Child-Pugh class C cirrhotic patients suffer from down-regulation of HLA-DR expression. Endotoxemia, possibly mediated by IL-10, contributes to this HLA-DR down-regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328986     DOI: 10.1016/j.jhep.2006.12.018

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  54 in total

1.  Effect of hyperbaric oxygen and ulinastatin on plasma endotoxin, soluble CD14, endotoxin-neutralizing capacity and cytokines in acute necrotizing pancreatitis.

Authors:  Jing Hou; Ming-Wei Zhu; Xiu-Wen He; Jun-Ming Wei; Yong-Guo Li; Da-nian Tang
Journal:  Can J Surg       Date:  2010-08       Impact factor: 2.089

Review 2.  Transcriptional control of mitochondrial biogenesis and its interface with inflammatory processes.

Authors:  Claude A Piantadosi; Hagir B Suliman
Journal:  Biochim Biophys Acta       Date:  2012-01-14

3.  Kinetic characteristics of euflammation: the induction of controlled inflammation without overt sickness behavior.

Authors:  Andrew J Tarr; Xiaoyu Liu; Nathaniel S Reed; Ning Quan
Journal:  Brain Behav Immun       Date:  2014-06-12       Impact factor: 7.217

4.  Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Naga S Betrapally; Phillip B Hylemon; Douglas M Heuman; Kalyani Daita; Melanie B White; Ariel Unser; Leroy R Thacker; Arun J Sanyal; Dae Joong Kang; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Hepatology       Date:  2015-05-06       Impact factor: 17.425

Review 5.  Hepatosplanchnic circulation in cirrhosis and sepsis.

Authors:  Meghan Prin; Jan Bakker; Gebhard Wagener
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

6.  Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Andrew Fagan; Melanie B White; Edith A Gavis; Phillip B Hylemon; Robert Brown; Chathur Acharya; Douglas M Heuman; Michael Fuchs; Swati Dalmet; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  JCI Insight       Date:  2018-03-08

7.  Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis.

Authors:  Henning W Zimmermann; Sebastian Seidler; Jacob Nattermann; Nikolaus Gassler; Claus Hellerbrand; Alma Zernecke; Jens J W Tischendorf; Tom Luedde; Ralf Weiskirchen; Christian Trautwein; Frank Tacke
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

8.  Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis.

Authors:  D Manno; M Puoti; L Signorini; G Lapadula; B Cadeo; L Soavi; G Paraninfo; R Allegri; G Cristini; P Viale; G Carosi
Journal:  Infection       Date:  2009-07-23       Impact factor: 3.553

Review 9.  Redox regulation of mitochondrial biogenesis.

Authors:  Claude A Piantadosi; Hagir B Suliman
Journal:  Free Radic Biol Med       Date:  2012-09-19       Impact factor: 7.376

10.  Bedside sublingual video imaging of microcirculation in assessing bacterial infection in cirrhosis.

Authors:  Muhammad Y Sheikh; Usman Javed; Jasjit Singh; Jayanta Choudhury; Omer Deen; Kulraj Dhah; Michael W Peterson
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.